We are live on ! Find out more
TTOO

T2 Biosystems, Inc
TTOO

Delisted

TTOO was delisted on the 11th of February, 2025.

Back to rankings

41 hedge funds and large institutions have $151M invested in T2 Biosystems, Inc in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

21% more call options, than puts

Call options by funds: $265K | Put options by funds: $219K

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

2% less capital invested

Capital invested by funds: $155M → $151M (-$3.78M)

15% less funds holding

Funds holding: 48 → 41 (-7)

60% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 10

Holders
41
Holders Change
-7
Holders Change %
-14.58%
% of All Funds
1.09%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
4
Increased
10
Reduced
5
Closed
10
Calls
$265K
Puts
$219K
Net Calls
+$46K
Net Calls Change
-$38K

Top Buyers

Rank Fund Capital Flow
1
LIM
Lagoda Investment Management
New York
+$3.02M
2
SM
Senvest Management
New York
+$1.64M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$526K
4
TM
Tiger Management
New York
+$427K
5
PVI
Pura Vida Investments
New York
+$394K

Top Sellers

Rank Fund Capital Flow
1
GGHC
Gilder Gagnon Howe & Co
New York
-$3.25M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$1.77M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.05M
4
SIM
Spark Investment Management
New York
-$791K
5
EIM
Essex Investment Management
Massachusetts
-$624K
Name Holding Trade Value Shares
Change 		Change in
Stake
Goldman Sachs
1
Goldman Sachs
New York
$30.8M – – –
AC
2
Aisling Capital
New York
$20.5M – – –
FP
3
Flagship Pioneering
Massachusetts
$15.8M +$14.3M +435 New
SM
4
Senvest Management
New York
$13.7M +$1.64M +50 +15%
LIM
5
Lagoda Investment Management
New York
$13.6M +$3.02M +92 +32%
PVMCV
6
Polaris Venture Management Co V
Massachusetts
$13.6M – – –
Wellington Management Group
7
Wellington Management Group
Massachusetts
$10.6M -$1.05M -32 -10%
TM
8
Tiger Management
New York
$9.47M +$427K +13 +5%
Point72 Asset Management
9
Point72 Asset Management
Connecticut
$5.43M -$1.77M -54 -26%
Vanguard Group
10
Vanguard Group
Pennsylvania
$4.25M +$526K +16 +16%
BFA
11
BlackRock Fund Advisors
California
$2.85M +$98.5K +3 +4%
EIM
12
Essex Investment Management
Massachusetts
$1.73M -$624K -19 -28%
BIT
13
BlackRock Institutional Trust
California
$1.56M +$131K +4 +10%
State Street
14
State Street
Massachusetts
$1.37M +$65.7K +2 +6%
Northern Trust
15
Northern Trust
Illinois
$1.29M +$32.8K +1 +3%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$809K – – –
PVI
17
Pura Vida Investments
New York
$441K +$394K +12 New
BIM
18
BlackRock Investment Management
Delaware
$395K – – –
Bank of New York Mellon
19
Bank of New York Mellon
New York
$317K – – –
WC
20
Woodstock Corp
Massachusetts
$270K – – –
California State Teachers Retirement System (CalSTRS)
21
California State Teachers Retirement System (CalSTRS)
California
$224K – – –
SC
22
Sculptor Capital
New York
$219K +$197K +6 New
USAA
23
United Services Automobile Association
Texas
$218K – – –
Morgan Stanley
24
Morgan Stanley
New York
$193K -$32.8K -1 -17%
WMSA
25
Weiss Multi-Strategy Advisers
New York
$181K +$65.7K +2 +67%
1
2 3

TTOO Hedge Fund Activity: Q3 2016 in Review

41 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q3 2016, worth a combined $151M — down 2.4% from $155M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of TTOO and 4 opened new positions — a net loss of 6 holders — while 5 trimmed existing stakes and 10 added.

The largest buyer was Lagoda Investment Management, adding an estimated $3.02M. The largest seller was Gilder Gagnon Howe & Co, exiting entirely with an estimated $3.25M sold.

  • 41 institutional investors held T2 Biosystems, Inc (TTOO) as of Q3 2016, down from 48 in Q2 2016.
  • Funds reported $151M of T2 Biosystems, Inc stock for Q3 2016, down 2.4% quarter-over-quarter.
  • 4 funds opened new T2 Biosystems, Inc positions in Q3 2016 and 10 closed out, a net change of -6 holders.
  • The largest T2 Biosystems, Inc buyer in Q3 2016 was Lagoda Investment Management, an estimated $3.02M added.
  • The largest T2 Biosystems, Inc seller in Q3 2016 was Gilder Gagnon Howe & Co, an estimated $3.25M sold.

Based on aggregated 13F filings for Q3 2016.